HRT and Weight Loss: What the Research Shows

Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

HRT and weight loss is a question with a narrow answer. Menopausal hormone therapy (HRT) is approved to treat symptoms like hot flashes, and the Premarin label I checked does not list weight loss, but several randomized trials found that women on it gained a little less weight and less belly fat than women on placebo or no treatment. I’m not a medical professional, so this page sticks to what the studies measured and what the FDA label says. For the bigger picture, start with my guide to weight loss during menopause.

Table of Contents

Does HRT help with weight loss?

Not directly. The FDA label for Premarin, an estrogen tablet, lists treatment of moderate to severe hot flashes and vaginal symptoms, treatment of low estrogen from ovarian failure, palliation of certain cancers, and prevention of postmenopausal osteoporosis. Weight loss isn’t on that list, according to the Premarin tablets label on DailyMed (label text revised April 2025; DailyMed version dated June 4, 2026; read October 24, 2026).

What the trials do show is a smaller gain. In the PEPI randomized trial, women on oral conjugated estrogens gained about 1 kilogram (2.2 pounds) less than women on placebo over 3 years. That’s modest, and it’s about gaining less, not losing.

What did the trials measure about HRT and weight?

The studies used different hormone regimens, so don’t read these numbers as one combined result.

Study	Who and how long	What it found
PEPI trial (Espeland, 1997)	875 women, randomized and placebo controlled, 3 years	Oral conjugated estrogens, with or without a progestogen, averaged 1.0 kg less weight gain and 1.2 cm less increase in waist girth than placebo
Danish Osteoporosis Prevention Study (Jensen, 2003)	2,016 women aged 45 to 58, early after menopause, 1,000 randomized in an open trial, 5 years	Weight rose 1.94 kg with HRT and 2.57 kg without; the smaller gain was almost entirely less fat
Women’s Health Initiative estrogen plus progestin substudy (Chen, 2005)	835 women, mean age 63.1, about 13.8 years past menopause, 3 years	Less loss of lean tissue (0.04 kg vs 0.44 kg) and a smaller trunk-to-leg fat ratio; the authors called the effects small
Meta-analysis (Salpeter, 2006)	Randomized trials of at least 8 weeks, searched through October 2004	Abdominal fat 6.8 percent lower with HRT in the trials that measured it (confidence interval 1.9 to 11.8 percent lower)

Sources: Espeland et al., J Clin Endocrinol Metab, 1997; Jensen et al., J Bone Miner Res, 2003; Chen et al., Am J Clin Nutr, 2005; Salpeter et al., Diabetes Obes Metab, 2006.

Two limits matter. The Danish trial was open label, meaning women knew whether they were on HRT, and the Salpeter meta-analysis pooled many kinds of trials and stopped searching in 2004.

Does HRT reduce belly fat?

It may slow the shift toward belly fat, but the effect is small and the studies are older. Each study measured something different: PEPI tracked waist girth, the Women’s Health Initiative substudy tracked upper-body fat distribution, and Salpeter pooled abdominal fat. In the Women’s Health Initiative substudy, women on estrogen plus progestin had a smaller trunk-to-leg fat ratio after 3 years (a change of minus 0.025 versus plus 0.004 on placebo).

An International Menopause Society review by Davis and colleagues says weight gain itself can’t be pinned on the menopause transition, but the hormone shift is linked to more total body fat and more abdominal fat. It also concludes that estrogen therapy may partly prevent this change in body composition, and it calls for more studies to find which women would benefit most. The National Institute on Aging describes the transition in plainer terms: during it the body begins to use energy differently and fat distribution changes.

None of this means HRT melts existing belly fat. The Danish and Women’s Health Initiative results are about fat gained or redistributed over years. Salpeter’s 6.8 percent is a pooled group average across many kinds of trials, not a promise of fat loss for any one woman.

Does HRT help you keep muscle?

The evidence is mixed. In the Women’s Health Initiative substudy above, women on HRT lost less lean tissue at 3 years. But a 2019 JAMA Network Open meta-analysis of 12 randomized trials and 4,474 women (average age 59, median follow-up 2 years) found HRT users lost only 0.06 kg less lean mass than controls, a difference that was not statistically significant, and rated the evidence quality low.

The six-year Women’s Health Initiative follow-up fits that picture. Lean mass at 6 years was no different between HRT and control groups, even though it looked better at 3 years. Resistance training is another route, which I cover in my guide to strength training for women over 40.

Can HRT cause weight gain?

In these trials, no. The PEPI and Danish studies found less gain on HRT, not more. The Premarin label reports first-year data from a 2-year trial of 2,333 women with a uterus, ages 40 to 65. Weight gain was listed as a treatment-related reaction in 11 of 348 women (3 percent) on the 0.625 mg dose and 14 of 332 (4 percent) on placebo.

The Danish trial tied weight gain mainly to declining physical fitness. The Premarin label also lists weight changes among reported reactions in its adverse reaction section, so the “no” above is about these trials, not the label’s position. If your weight climbed after starting HRT, tell the clinician who prescribed it; don’t assume it’s the hormones and don’t stop on your own.

Why would hormones change weight and fat in menopause?

Davis and colleagues report that studies mostly indicate improved insulin sensitivity with estrogen therapy, so researchers have also looked at metabolic markers. The evidence is mixed. Salpeter’s meta-analysis reported lower insulin resistance with HRT, and in the 727-woman KEEPS trial of women 6 to 36 months past their last period, insulin resistance decreased with transdermal estradiol. But Marlatt and colleagues, in a review in the journal Obesity, write that study findings do not currently support that hormone therapy consistently improves insulin sensitivity, and that the glucose findings are conflicting.

So the honest summary is this: hormones are one piece of midlife weight change, and HRT doesn’t replace food, movement and sleep. My page on postmenopause weight loss goes through the other pieces.

Does HRT help weight through better sleep?

Unknown. The trials above did not test that. The 2022 position statement of the North American Menopause Society, now called The Menopause Society, says hormone therapy remains the most effective treatment for hot flashes and night sweats. I look at how sleep connects to weight on my page about sleep and menopause weight gain. Whether that symptom relief changes body weight through better sleep wasn’t measured in the trials above.

Who should not use HRT, and what are the risks?

HRT isn’t right for everyone. MedlinePlus says you should not use hormone therapy for menopause if you are pregnant, have unexplained vaginal bleeding, have had certain cancers, a stroke or heart attack, blood clots or liver disease. Risk depends on the type, how long you use it, and your history.

The Premarin label’s contraindications also include estrogen-dependent neoplasia (tumors), protein C, protein S or antithrombin deficiency, and a history of breast cancer with narrow exceptions.

On February 12, 2026, the FDA approved label changes for six hormone therapy products that remove the cardiovascular disease, breast cancer and probable dementia statements from the boxed warning. Its consumer update says the cardiovascular disease and breast cancer risks remain in the Warnings and Precautions section, and that the boxed warning for endometrial cancer stays on estrogen-alone products. The Premarin tablets label on DailyMed (label text revised April 2025; DailyMed version dated June 4, 2026) still shows the older boxed warning, so check the current label for the specific product you’re considering.

Timing matters too. The Menopause Society statement says that for women younger than 60 or within 10 years of menopause onset with no contraindications, the benefit-risk ratio is favorable for bothersome hot flashes and prevention of bone loss. For women who start more than 10 years after onset or after age 60, it appears less favorable because of greater absolute risks of heart disease, stroke, blood clots and dementia. The Women’s Health Initiative substudy above enrolled women averaging 63 and nearly 14 years past menopause, outside that window.

Can you use HRT and a GLP-1 medicine together?

Some women do, and one small study looked at it. A Mayo Clinic retrospective study of 106 postmenopausal women taking semaglutide for overweight or obesity compared 16 women who also used hormone therapy with 90 who did not. At 12 months, total body weight loss was 16 percent in the HRT group and 12 percent in the no-HRT group, and the difference held after adjusting for other factors. The authors said larger studies are needed to confirm the result. One author reports stock and consulting ties to several companies, including obesity drug developers.

Sixteen women is a very small group, and a retrospective study can’t show that HRT caused the extra loss. It isn’t a reason to start HRT for weight.

If weight is your main goal, the FDA label for Wegovy lists, among other uses, weight reduction together with a reduced calorie diet and more physical activity to reduce excess body weight in adults with obesity, or with overweight plus at least one weight-related condition. It’s contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. See my page on GLP-1 weight loss for the evidence.

If you and a clinician decide to explore a GLP-1 medicine, telehealth is one route. Shed is a telehealth company, and its page (read October 24, 2026) says a medical provider reviews your health form to decide whether treatment is a good fit. It lists compounded semaglutide starting at $199 per month and states that compounded medications are not FDA-approved. We may earn a commission if you sign up through that link, which is why the evidence comes first on this page. Nothing in the studies above tested a Shed program.

What should you ask a clinician about HRT and weight?

Bring specific questions to the appointment:

Given my age, time since my last period and health history, is HRT an option for my symptoms?
Do I have any condition on the label’s contraindication list?
Would a patch, pill or another form suit me?
If weight is a concern, what else belongs in the plan?

A clinician who works with menopause is the right person for this. If you’d like to look at non-prescription options too, my page on the best supplements for perimenopause covers what the research says about each.

I’m not a medical professional, and nothing on this page is advice to start, stop or change any medicine. Hormone therapy decisions depend on your health history, so make them with the clinician who prescribes for you.

Frequently Asked Questions

Is HRT approved by the FDA for weight loss?

No. The label I checked, Premarin, lists symptom relief, hormone deficiency, cancer palliation and osteoporosis prevention as its uses, and weight loss is not among them.

Does estrogen help you lose belly fat?

The trials suggest estrogen may reduce how much abdominal fat women gain after menopause, but the Danish and Women’s Health Initiative results are about fat gained or redistributed over years, and the pooled meta-analysis figure is a group average. The effect sizes were small.

Does the type of HRT matter for weight?

The weight studies don’t answer that well. PEPI tested oral conjugated estrogens. In Salpeter’s meta-analysis, oral agents had larger effects on metabolic markers than patches, but they also raised C-reactive protein and lowered protein S, while patches did not. Your clinician decides which form suits you.

How long does HRT take to change weight?

The two main weight trials followed women for 3 years (PEPI) and 5 years (Danish trial) and reported the difference at the end, so they can’t say when a difference first appears. Treat any effect on the scale as slow and small.

Is HRT still an option after age 60?

It can be, but the balance changes. The Menopause Society says the benefit-risk ratio appears less favorable after age 60 or more than 10 years past menopause onset, because absolute risks of heart disease, stroke, blood clots and dementia are greater. A clinician has to weigh your own history.

Can a supplement do what HRT does for weight?

None of the studies cited here tested a supplement, so they can’t tell you that. A pharmacist can check any supplement for interactions with your medicines.

Sources

HRT and Weight Loss in Menopause: What Trials Show